[HTML][HTML] Treatment of schizophrenia evaluated via the pharmacopsychometric triangle—An integrative approach with emphasis on well-being and functioning

P Kølbæk, O Mors, CU Correll, SD Østergaard - Schizophrenia, 2023 - nature.com
… (SR) and buspirone augmentation of citalopram, finding that bupropion-SR was superior in
… However, this study was based on re-analysis of data from a placebo-controlled clinical trial

Adjunctive strategies for treatment-resistant depression

ME Thase - Managing Treatment-Resistant Depression, 2022 - Elsevier
… , the STAR*D research project included a head-to-head trial … ) or “augmentation” of
citalopram by either buspirone or … In summary, the results of three RCTs indicate that buspirone

Clinical research challenges posed by difficult-to-treat depression

AJ Rush, HA Sackeim, CR Conway… - Psychological …, 2022 - cambridge.org
Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation
of citalopram in the STAR*D trial. Acta Psychiatrica Scandinavica, 125, 342–348. doi: …

[HTML][HTML] Obesogenic medications and weight gain over 24 weeks in patients with depression: results from the GUIDED study

JG Fiedorowicz, L Brown, J Li, SV Parikh… - Psychopharmacology …, 2021 - ncbi.nlm.nih.gov
… VAST-D trial, the bupropion arms (change or augmentation) … from an initially randomized
clinical trial in which clinically-… the referent comparator citalopram although unexpectedly so too …

The Hamilton rating scales for depression: a critical review of clinimetric properties of different versions

D Carrozzino, C Patierno, GA Fava… - Psychotherapy and …, 2020 - karger.com
… HAM-D17 in capturing the antidepressant effects of citalopram. In another study, Bech et al.
[… efficacy of bupropion over buspirone. Many other studies reported similar results: the HAM-…

A Chinese adaptation of six items, self-report Hamilton Depression Scale: factor structure and psychometric properties

XM Wang, HY Ma, J Zhong, XJ Huang, CJ Yang… - Asian Journal of …, 2022 - Elsevier
… At present, studies have proved that routine use of outcome … contain common antidepressant
side effects, which contribute … the symptoms and clinical outcomes of patients, some studies …

[HTML][HTML] Quantitative magnetic resonance spectroscopy of depression: The value of short-term metabolite changes in predicting treatment response

R Wang, Y Shen, G Li, R Du, A Peng - Frontiers in Neuroscience, 2022 - frontiersin.org
… , all MDD patients were treated with citalopram for 3 weeks to … to the next stage for
augmented treatment with bupropion (n … the outcome of treatment response, and our results also …